bunazosin has been researched along with Coronary Heart Disease in 7 studies
bunazosin: structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although carvedilol attenuates left ventricular (LV) remodeling in coronary occlusion-reperfusion, it is not known whether it attenuates ischemic LV remodeling because of coronary stenosis (CS) or permanent coronary occlusion (CO)." | 7.71 | Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. ( Maehara, K; Maruyama, Y; Sakabe, A; Yaoita, H, 2002) |
| "Although carvedilol attenuates left ventricular (LV) remodeling in coronary occlusion-reperfusion, it is not known whether it attenuates ischemic LV remodeling because of coronary stenosis (CS) or permanent coronary occlusion (CO)." | 3.71 | Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. ( Maehara, K; Maruyama, Y; Sakabe, A; Yaoita, H, 2002) |
| "Pretreatment with bunazosin inhibited the decrease in ATP and the increase in AMP caused by ischemia, resulting in the high value of ECP in the ischemic myocardium." | 1.28 | Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart. ( Abiko, Y; Ichihara, K; Yoshida, R, 1990) |
| "In the bunazosin group, none developed arrhythmias." | 1.27 | Biochemical basis for reperfusion arrhythmias. ( Ozawa, T; Sugiyama, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakutani, A | 1 |
| Bando, S | 1 |
| Shinomiya, H | 1 |
| Noda, T | 1 |
| Minezono, K | 1 |
| Mori, H | 1 |
| Yaoita, H | 1 |
| Sakabe, A | 1 |
| Maehara, K | 1 |
| Maruyama, Y | 1 |
| Tanaka, H | 1 |
| Obata, H | 1 |
| Haneda, T | 1 |
| Katoh, T | 1 |
| Mori, F | 1 |
| Miyamoto, M | 1 |
| Esato, K | 1 |
| Yoshida, R | 1 |
| Ichihara, K | 1 |
| Abiko, Y | 1 |
| Sugiyama, S | 1 |
| Ozawa, T | 1 |
| Katagiri, T | 1 |
| Mochizuki, M | 1 |
| Umetsu, K | 1 |
| Hiroshige, J | 1 |
| Geshi, E | 1 |
| Konno, N | 1 |
7 other studies available for bunazosin and Coronary Heart Disease
| Article | Year |
|---|---|
[Effects of E-643 on the regional myocardial function and hemodynamics in experimental acute coronary artery occlusion].
Topics: Adrenergic alpha-Antagonists; Animals; Coronary Disease; Dogs; Hemodynamics; Myocardial Contraction; | 1983 |
Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Ascorbic Acid; Carbazoles; Cardi | 2002 |
Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Atenolol; Blood Pre | 1991 |
Effect of combined dopamine and bunazosin on the ischemic heart after occlusion of the coronary artery.
Topics: Adrenergic alpha-Antagonists; Animals; Arterial Occlusive Diseases; Cardiac Output, Low; Coronary Ci | 1990 |
Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart.
Topics: Adenine Nucleotides; Adrenergic alpha-Antagonists; Animals; Carbohydrate Metabolism; Coronary Diseas | 1990 |
Biochemical basis for reperfusion arrhythmias.
Topics: Adrenergic alpha-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; Coronary Circulation; Coronary | 1987 |
Protection of acute ischemic myocardial injury by pharmacological intervention.
Topics: Adenosine Triphosphatases; Adrenergic alpha-Antagonists; Animals; Calcium; Calcium-Transporting ATPa | 1989 |